Beneficial role of l-arginine in cardiac matrix remodelling in insulin resistant rats

European Journal of Clinical Investigation

Volumn 38, Issue 11, 2008, Pages 849-856

  Monti, L D ^a   Galluccio, E ^a   Lucotti, P ^a   Setola, E ^a   Costa, S ^a   Fontana, B ^a   Oldani, M ^a   Merante, D ^c   Di Blasi, P ^c   Bosi, E ^a,b   Piatti, P M ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c GSK   (Italy)

Author keywords

Cardiac remodelling; Insulin resistance; Matrix metalloproteinases; Metabolic syndrome; Sucrose diet

Indexed keywords

ARGININE; CYCLIC GMP; FATTY ACID; GELATINASE A; GELATINASE B; GLUCOSE; INSULIN; SUCROSE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; HEART VENTRICLE REMODELING; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETROPERITONEAL FAT;

ADIPOSE TISSUE; ANIMALS; ARGININE; BLOOD GLUCOSE; DIETARY SUCROSE; DIETARY SUPPLEMENTS; FATTY ACIDS, NONESTERIFIED; GLUCOSE TOLERANCE TEST; HEART; INSULIN; INSULIN RESISTANCE; MALE; MATRIX METALLOPROTEINASES; METABOLIC SYNDROME X; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 54349126657     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02027.x     Document Type: Article

References (32)

1. Boivin A, Deshaies Y. Dietary rat models in which the development of hypertriglyceridemia and that of insulin resistance are dissociated. Metabolism 1995 44 : 1540 7.
2. Frayne KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993 4 : 197 204.
3. Krssak M, Falk Petersen K, Dresner A, Di Pietro L, Vogel SM, Rothman DL et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999 42 : 113 6.
4. Gaudiot N, Ribiere C, Jaubert AM, Giudicelli Y. Endogenous nitric oxide is implicated in the regulation of lipolysis through antioxidant-related effect. Am J Physiol Cell Physiol 2000 279 : C1603 10.
5. Khedara A, Kawai Y, Kayashita J, Kato N. Feeding rats the nitric oxide synthase inhibitor, L-N (omega) nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation. J Nutr 1996 126 : 2563 7.
6. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F et al. Long-term oral 1-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 2001 24 : 875 80.
7. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE et al. Dietary 1-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 2005 135 : 714 21.
8. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000 1477 : 267 83.
9. Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003 168 : 263 9.
10. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodelling and atherogenesis. The good, the bad, and the ugly. Circ Res 2002 90 : 951 62.
11. Lusis AJ. Atherosclerosis. Nature 2000 407 : 233 41.
12. Podolin DA, Sutherland E, Iwahashi M, Simon FR. A high sucrose diet alters lipid composition and fluidity of liver sinusoidal membranes. Horm Metab Res 1998 30 : 195 9.
13. Gonsolin D, Couturier K, Garait B, Rondel S, Novel-Chatè V, Peltier S et al. High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery. Mol Cell Biochem 2007 295 : 217 28.
14. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 2000 278 : E501 8.
15. Chen N-G, Reaven GM. Fatty acid inhibition of glucose-stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats. Metabolism 1999 48 : 1314 7.
16. Lucotti PC, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP et al. Beneficial effects of oral 1-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006 291 : E906 12.
17. Milkiewicz M, Kelland C, Colgan S, Haas TL. Nitric oxide and p38 MAP kinase mediate shear stress-dependent inhibition of MMP-2 production in microvascular endothelial cells. J Cell Physiol 2006 208 : 229 37.
18. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001 50 : 241 7.
19. Xue CY, Kageyama H, Kashiba M, Kobayashi A, Osaka T, Namba Y et al. Different origin of hypertriglyceridemia induced by a high-fat and a high-sucrose diet in ventromedial hypothalamic-lesioned obese and normal rats. Int J Obes Relat Metab Disord 2001 25 : 434 8.
20. Grant KI, Marais MP, Dhansay MA. Sucrose in a lipid-rich meal amplifies the postprandial excursion of serum and lipoprotein triglyceride and cholesterol concentrations by decreasing triglyceride clearance. Am J Clin Nutr 1994 59 : 853 60.
21. Pagliassotti MJ, Prach PA, Koppenhafer TA, Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol 1996 271 : R1319 26.
22. Monti LD, Landoni C, Setola E, Galluccio E, Lucotti P, Sandoli EP et al. Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. Am J Physiol Heart Circ Physiol 2004 287 : H1225 31.
23. Piatti PM, Monti LD, Baruffaldi L, Magni F, Paroni R, Fermo I et al. Effects of an acute increase in plasma triglyceride levels on glucose metabolism in man. Metabolism 1995 44 : 883 9.
24. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000 106 : 171 6.
25. Avendano GF, Agarwal RK, Bashey RI, Lyons MM, Soni BJ, Jyothirmayi GN et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 1999 48 : 1443 7.
26. Wang W, Viappiani S, Sawicka J, Schullz R. Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release. Br J Pharmacol 2006 17 : 571 88.
27. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 2000 20 : E120 6.
28. Lafont A, Durand E, Samuel JL, Besse B, Addad F, Levy BI et al. Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty. Circulation 1999 100 : 1109 15.
29. Dutta K, Podolin DA, Davidson MB, Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 2001 50 : 1186 92.
30. Rodriguez WE, Joshua IG, Falcone JC, Tyagi SC. Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2006 291 : H81 7.
31. McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med 2006 144 : 517 24.
32. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004 18 : 1692 700.